CINTREX

Serial Number 78957727
602

Registration Progress

Application Filed
Aug 22, 2006
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: CINTREX
Previous Owner: NeoPharm, Inc.
Classes: 005

Trademark Image

CINTREX

Basic Information

Serial Number
78957727
Filing Date
August 22, 2006
Abandonment Date
November 19, 2007
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Dec 14, 2007
Classes
005

Rights Holder

NeoPharm, Inc.

03
Address
1850 Lakeside Drive
Waukegan, IL 60085

Ownership History

NeoPharm, Inc.

Original Applicant
03
Waukegan, IL

Legal Representation

Attorney
Larisa R Lacis

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

16 events
Date Code Type Description Documents
Dec 14, 2007 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Dec 14, 2007 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Dec 7, 2007 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 7, 2007 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 18, 2007 CNFR O FINAL REFUSAL MAILED Loading...
May 17, 2007 CNFR R FINAL REFUSAL WRITTEN Loading...
May 7, 2007 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
May 7, 2007 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 7, 2007 ALIE A ASSIGNED TO LIE Loading...
Apr 11, 2007 MAIL I PAPER RECEIVED Loading...
Mar 22, 2007 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 22, 2007 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 23, 2007 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 23, 2007 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 17, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 28, 2006 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparation for the treatment of cancer
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005